Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,354,465,400
-$404,217,847 QoQ
Shares Held
17,690,462
-7.2% QoQ
Ownership
1.14%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#12
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 33%
Shared 0%
None 67%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $41,356,581,132 across 16 Drug Manufacturers - General names. AZN ranks #5 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,274,243 | $13,522,666,405 | |
| 2 | JNJ |
Johnson & Johnson
|
23,438,141 | $5,952,584,668 | |
| 3 | ABBV |
AbbVie Inc.
|
21,237,764 | $5,344,270,929 | |
| 4 | MRK |
Merck & Co., Inc.
|
30,535,208 | $3,923,774,226 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
17,690,462 | $3,354,465,400 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
18,649,065 | $2,356,122,869 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
34,045,352 | $1,961,693,176 | |
| 8 | AMGN |
Amgen Inc
|
5,058,830 | $1,831,903,515 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,354,465,400 | 17,690,462 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,758,683,247 | 19,058,327 | Shares | Defined | 2026-05-18 | |
| No filing history on record for this holder in this stock. | ||||||